SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000886163-06-000116
Filing Date
2006-10-17
Accepted
2006-10-17 16:55:33
Documents
3
Period of Report
2006-10-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.03: Material Modifications to Rights of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 RIGHTS PLAN ligand1016068k.txt 8-K 14271
2 PREFERRED SHARES RIGHTS AGREEMENT ex4-1.txt EX-4 144230
3 PRESS RELEASE ex99-1.txt EX-99 5489
  Complete submission text file 0000886163-06-000116.txt   165724
Mailing Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117
Business Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117 8585507500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-20720 | Film No.: 061149113
SIC: 2834 Pharmaceutical Preparations